Ryota Nishimori
President en CAC HOLDINGS CORPORATION .
Fortuna: 623 212 $ al 31/03/2024
Perfil
Ryota Nishimori is currently the President & Representative Director at CAC Holdings Corp.
since 2021 and the President & Representative Director at CAC Corp.
(Japanese) since 2014.
He previously served as the President & Director at CAC America Corp.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CAC HOLDINGS CORPORATION
0.23% | 31/12/2022 | 48 000 ( 0.23% ) | 623 212 $ | 31/03/2024 |
Cargos activos de Ryota Nishimori
| Empresas | Cargo | Inicio |
|---|---|---|
| CAC HOLDINGS CORPORATION | President | 01/01/2021 |
CAC KK
 CAC KK Information Technology ServicesTechnology Services Part of CAC Holdings Corp., CAC Corp. (TY) is a Japanese company that supports all operations related to donations, significantly reducing time and effort while ensuring high transparency and safety. The private company is based in Tokyo, Japan. With standard functions, it can handle various types of applications, such as scholarships, general donations, academic society donations, research and development expenses, and donation applications from patient groups. Astellas Pharma, Novo Pharma, and several other pharmaceutical and medical device manufacturers have introduced this company. Founded in 2014. | President | 01/04/2014 |
Antiguos cargos conocidos de Ryota Nishimori.
| Empresas | Cargo | Fin |
|---|---|---|
| CAC America Corp. | President | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CAC HOLDINGS CORPORATION | Technology Services |
| Empresas privadas | 2 |
|---|---|
| CAC America Corp. | |
CAC KK
CAC KK Information Technology ServicesTechnology Services Part of CAC Holdings Corp., CAC Corp. (TY) is a Japanese company that supports all operations related to donations, significantly reducing time and effort while ensuring high transparency and safety. The private company is based in Tokyo, Japan. With standard functions, it can handle various types of applications, such as scholarships, general donations, academic society donations, research and development expenses, and donation applications from patient groups. Astellas Pharma, Novo Pharma, and several other pharmaceutical and medical device manufacturers have introduced this company. Founded in 2014. | Technology Services |
- Bolsa de valores
- Insiders
- Ryota Nishimori
